Sana Biotech To Establish Manufacturing Facility For Gene, Cell Therapy Candidates

Sana Biotechnology Inc (NASDAQ:SANA) has entered into a lease agreement to develop a 163,000 square foot manufacturing facility in Fremont, California.
The facility will support the manufacture of Sana's late-stage clinical development and early commercial product candidates.
The facility will be designed to provide manufacturing capabilities across Sana's portfolio, including allogeneic T cell, viral vector, and pluripotent stem cell production.
The Company also plans to work with contract manufacturing partners to advance its product candidates to the clinic as early as next year.
Price Action: SANA shares closed at $17.42 on Wednesday.